 SROA is now accepting abstract submissions for the 2012 Annual Meeting to be held in Cambridge, MA from October 27-31. Please complete your submission by March 19, 2012.
Click Here to Submit an Abstract
 Consider serving your society. Call for nominations for the Board of Directors is now open. Please submit all nominations by Wednesday, February 15, 2012. Click here to nominate a colleague or yourself.
SROA wants to recognize outstanding members of the Society and in the field of radiation oncology administration. Click here to learn more.
Commit to Greater Patient Safety: Sign the Pledge
The Society for Radiation Oncology Administrators (SROA) is asking radiation oncology administrators, physicians, physicists, dosimetrists and radiation therapists to sign a pledge that raises awareness of how much this team accomplishes in keeping patients and coworkers safe during treatments.
Based on a yearly average of one million patients undergoing radiation therapy in the United States, the SROA Advocacy Committee created a commitment that can benefit radiation oncology professionals and their patients. While recent news reports have centered on the tragic effects of errors and the many reasons they occur, the SROA pledge acknowledges that the radiation oncology team can make a difference.
This commitment to patient safety recognizes that everyone on the team is human and can benefit from a “time out.” It is a proactive approach to a life-saving treatment that so many patients must depend on.
You can download the “Safety Pledge” file or copy and distribute the document throughout your departments. For more ideas on how to pass this commitment forward, visit this site regularly.
Sincerely,
SROA Board of Directors and Advocacy Committee
Radiation Oncology News Briefs
Management Moment: Tell a colleague about the benefits of SROA membership. Or just guide a fellow administrator to this website with the intention of showing them how they can contribute to the radiation oncology community, then vote on the SROA Board members who will guide the organization.
Gene in Brain Tumor Increases Response to Radiation Therapy Combined with Chemo
Combining radiation therapy with chemotherapy almost doubled the median survival time for patients with a form of brain tumor called an oligodendroglioma that has a chromosomal abnormality called an 1p19q deletion. Read more ...
Trial Indicates No Long-term Benefit Associated With Yearly Prostate Cancer Screening The death rate from prostate cancer in the Prostate, Lung Colorectal and Ovarian (PLCO) randomized screening trial did not decrease after 13 years of follow-up, despite a 12 percent increase in finding prostate cancer using the prostate-specific antigen (PSA) and digital rectal examination (DRE) screenings, according to a National Cancer Institute "Special Report." Read more ...
|
